XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Income (Deficit)
Beginning balances (in shares) at Dec. 31, 2022   76,914,590      
Beginning balances at Dec. 31, 2022 $ 808,285 $ 77 $ 844,842 $ (5,578) $ (31,056)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   363,190      
Issuance of common stock under the Employee Stock Purchase Plan 8,822   8,822    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   635,495      
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (10,687) $ 1 (10,688)    
Stock repurchased during the period (in shares)   536,372      
Purchase and retirement of common stock (19,801) $ (1) (19,800)    
Stock-based compensation 38,272   38,272    
Other comprehensive income (loss) 1,526     1,526  
Net income 82,387       82,387
Ending balances (in shares) at Dec. 30, 2023   77,376,903      
Ending balances at Dec. 30, 2023 908,804 $ 77 861,448 (4,052) 51,331
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   340,989      
Issuance of common stock under the Employee Stock Purchase Plan 9,748   9,748    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   706,376      
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (19,983) $ 0 (19,983)    
Stock repurchased during the period (in shares)   1,309,635      
Purchase and retirement of common stock (53,379) $ 0 (53,379)    
Stock-based compensation 39,752   39,752    
Other comprehensive income (loss) (6,788)     (6,788)  
Net income $ 69,614       69,614
Ending balances (in shares) at Dec. 28, 2024 77,114,633 77,114,633      
Ending balances at Dec. 28, 2024 $ 947,768 $ 77 837,586 (10,840) 120,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   385,189      
Issuance of common stock under the Employee Stock Purchase Plan 11,119   11,119    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   613,142      
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (12,402) $ 1 (12,403)    
Stock repurchased during the period (in shares)   800,000      
Purchase and retirement of common stock (26,168)   (26,168)    
Stock-based compensation 38,413   38,413    
Other comprehensive income (loss) 7,312     7,312  
Net income $ 54,361       54,361
Ending balances (in shares) at Dec. 27, 2025 77,647,935 77,647,935      
Ending balances at Dec. 27, 2025 $ 1,035,403 $ 78 863,547 $ (3,528) $ 175,306
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock Issued During Period, Shares, New Issues   334,971      
Stock Issued During Period, Value, New Issues $ 15,000 $ 0 $ 15,000